Home
Conditions
Malaria, Falciparum

Clinical trial condition

Malaria, Falciparum

Explore clinical trials studying Malaria, Falciparum. Study availability and eligibility vary by location and protocol.

368 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Malaria, Falciparum trial results

Completed

Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum Transmission

NCT04049916

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Malaria Research and Training Centre Bamako, Mali

Radboud university medical center Nijmegen, Netherlands

View Trial Details

Completed

Regimen Optimization Trial of PfSPZ Vaccine in Equatorial Guinea

NCT03590340

Conditions: Infections, Malaria, Malaria, Falciparum, +4 more
Locations: Baney Clinical Research Center Santiago de Baney, Bioko Island, Equatorial Guinea

View Trial Details

Completed

Pilot Study to Estimate the Burden and Distribution of Plasmodium Falciparum Malaria in Kalifabougou, Mali in Preparation for a Prospective Cohort Study of Naturally-Acquired Malaria Immunity

NCT01160562

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Malaria Research and Training Center Bamako, Mali

View Trial Details

Completed

Phase I Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and Mali

NCT00889616

Conditions: Infections, Malaria, Malaria, Falciparum, +4 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

Malaria Research and Training Center Bamako, Mali

View Trial Details

Completed

An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa

NCT02207816

Conditions: Infections, Malaria, Malaria, Falciparum, +4 more
Locations: GSK Investigational Site Ouagadougou, Burkina Faso

GSK Investigational Site Kisumu, Kenya

GSK Investigational Site Tanga, Tanzania

View Trial Details

Completed

Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in Cambodia

NCT02612545

Conditions: Acute Falciparum Malaria, Infections, Malaria, +5 more
Locations: National Center for Parasitology, Entomology, and Malaria Controk, Ministry of H Phnom Penh, Cambodia

View Trial Details

Completed

Safety and Immunogenicity of ChAd63 RH5 and MVA RH5 in Adults, Young Children and Infants Living in Tanzania

NCT03435874

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Ifakara Health Institute Clinical Trial Facility Bagamoyo, Tanzania

View Trial Details

Completed

Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)

NCT01345240

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +15 more
Locations: GSK Investigational Site Ouagadougou, Burkina Faso

GSK Investigational Site Kumasi, Ghana

View Trial Details

Completed

Cohort Event Monitoring Study of Pyramax®

NCT03201770

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: The Biotechnology Center Nkolbisson, Univ of Yaounde I, Messa Yaoundé, Cameroon

Institut Pierre Richet / Institut National de SanPublique (IPR/INSP) Bouaké, Côte d’Ivoire

Centre de Recherche du Centre Hospitalier du Mont Amba Kinshasa, Democratic Republic of the Congo

CERMEL, Albert Schweitzer Hospital Lambaréné, Gabon

View Trial Details

Completed

Safety, Tolerability and Efficacy of PfSPZ Vaccine in Healthy Children and Infants 5 Months - 9 Years Living in Kenya

NCT02687373

Conditions: Infections, Malaria, Malaria, Falciparum, +4 more
Locations: Center for Global Health Research, KEMRI Kisian, Siaya County, Kenya

View Trial Details

Malaria, Falciparum

Malaria, Falciparum trial results

Related conditions